126 related articles for article (PubMed ID: 17575148)
1. Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma.
Morgan R; Pirard PM; Shears L; Sohal J; Pettengell R; Pandha HS
Cancer Res; 2007 Jun; 67(12):5806-13. PubMed ID: 17575148
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
3. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.
Shears L; Plowright L; Harrington K; Pandha HS; Morgan R
J Urol; 2008 Nov; 180(5):2196-201. PubMed ID: 18804814
[TBL] [Abstract][Full Text] [Related]
4. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
5. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner.
Fernandez LC; Errico MC; Bottero L; Penkov D; Resnati M; Blasi F; Caré A
Cancer Lett; 2008 Aug; 266(2):144-55. PubMed ID: 18378073
[TBL] [Abstract][Full Text] [Related]
7. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
[TBL] [Abstract][Full Text] [Related]
8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
9. Privileged scaffolds for blocking protein-protein interactions: 1,4-disubstituted naphthalene antagonists of transcription factor complex HOX-PBX/DNA.
Ji T; Lee M; Pruitt SC; Hangauer DG
Bioorg Med Chem Lett; 2004 Aug; 14(15):3875-9. PubMed ID: 15225688
[TBL] [Abstract][Full Text] [Related]
10. In vitro impact of a whey protein isolate (WPI) and collagen hydrolysates (CHs) on B16F10 melanoma cells proliferation.
Castro GA; Maria DA; Bouhallab S; Sgarbieri VC
J Dermatol Sci; 2009 Oct; 56(1):51-7. PubMed ID: 19695839
[TBL] [Abstract][Full Text] [Related]
11. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential.
Lentini A; Forni C; Provenzano B; Beninati S
Amino Acids; 2007 Jan; 32(1):95-100. PubMed ID: 16699821
[TBL] [Abstract][Full Text] [Related]
13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
14. Melanoma activation of 3-o-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin to a potent irreversible inhibitor of dihydrofolate reductase.
Sánchez-del-Campo L; Tárraga A; Montenegro MF; Cabezas-Herrera J; Rodríguez-López JN
Mol Pharm; 2009; 6(3):883-94. PubMed ID: 19358568
[TBL] [Abstract][Full Text] [Related]
15. Suppression of growth and hepatic metastasis of murine B16FO melanoma cells by a novel nutrient mixture.
Roomi MW; Kalinovsky T; Roomi NW; Ivanov V; Rath M; Niedzwiecki A
Oncol Rep; 2008 Oct; 20(4):809-17. PubMed ID: 18813822
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput method for monitoring changes in homeobox gene expression.
Reese DH; Ramos-Valle M
Biochem Biophys Res Commun; 2007 Jun; 357(4):882-8. PubMed ID: 17459334
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
Cai L; Li X; Zheng S; Wang Y; Wang Y; Li H; Yang J; Sun J
Melanoma Res; 2009 Feb; 19(1):1-7. PubMed ID: 19430401
[TBL] [Abstract][Full Text] [Related]
18. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
[TBL] [Abstract][Full Text] [Related]
19. HER3 is a determinant for poor prognosis in melanoma.
Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
[TBL] [Abstract][Full Text] [Related]
20. Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism.
Giammarioli AM; Maselli A; Casagrande A; Gambardella L; Gallina A; Spada M; Giovannetti A; Proietti E; Malorni W; Pierdominici M
Cancer Res; 2008 Jul; 68(13):5291-300. PubMed ID: 18593930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
